Shares of Cytokinetics, Incorporated (CYTK) gained over 10% in recent trade Tuesday, after the company announced expansion of collaboration for development of CK-2127107 in spinal muscular atrophy and other neuromuscular indications. Cytokinetics said it expects to receive over $75 million in committed capital and reimbursements for planned activities.
CYTK shares recently gained 49 cents to $5.39. The stock is down more than 25.76% year-over-year and has lost roughly 24.62% year-to-date. In the past 52 weeks, shares of San Francisco, California-based clinical stage biopharmaceutical company have traded between a low of $3.05 and a high of $13.26.
Cytokinetics, Inc has a total market cap of $197.35 million.
Agios Pharmaceuticals, Inc. (AGIO) shares are down 15% to $103 in mid-day trading. The move comes on a strong volume too with the issue currently trading more than 1.65 million shares, compared to the average volume of 963,342. Not seeing any news or rumors to account for the move.
Agios Pharmaceuticals is a Cambridge, Massachusetts-based biopharmaceutical firm which focuses on the development of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Its stock has a median consensus analyst price target of $102 with a high target of $124.00, and a 52-week trading range of $21.40 to $124.39.
The T-12 profit margin at Agios Pharmaceuticals is (68.25%). AGIO‘s revenue for the same period is $57.47 million.
Agios Pharmaceuticals, Inc has a current market cap of $3.60 billion.
Peerless Systems Corp. (PRLS) moved 27% higher intraday on news the company has agreed to be acquired by Mobius Acquisition for $7.00 per share in cash, representing a premium of about 44% over Peerless’ average closing price during the 30 trading days ending Dec. 19. Peerless said once the transaction is completed it will become a privately held company. Peerless Systems board of directors has unanimously approved the agreement.
PRLS shares recently gained $1.46 to $6.84. The stock is up more than 48.26% year-over-year and has gained roughly 47.86% year-to-date. In the past 52 weeks, shares of Stamford, Connecticut-based tech company have traded between a low of $3.39 and a high of $6.94.
Peerless Systems Corp. closed Monday at $5.38. The name has a total market cap of $17.26M.
Robert W. Baird analysts downgraded Achillion Pharmaceuticals, Inc. (ACHN) Tuesday from ‘Outperform’ to ‘Neutral’ and raised their price target from $12 to $16. Achillion shares were down nearly 24% at $11.79 in midday trade, moving within a 52-week range of $2.45 to $16.87.
The move comes on a big volume too with the issue currently trading more than 19 million shares, which dwarfs the average volume of 6.28 million. ACHN is up more than 394% year-over-year and has gained roughly 366% year-to-date.
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!